Sara J. Adair

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment

Jayme B. Stokes, Sara J. Adair, Jill K. Slack‐Davis et al. · Molecular Cancer Therapeutics · 2011 · 240 citations · Full text

Medicine, Cancer Biology, Oncology +17

Drp1 Promotes KRas-Driven Metabolic Changes to Drive Pancreatic Tumor Growth

Sarbajeet Nagdas, Jennifer A. Kashatus, Aldo Nascimento et al. · Cell Reports · 2019 · 147 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells

Xiaolong Wei, Jiekun Yang, Sara J. Adair et al. · Proceedings of the National Academy of Sciences · 2020 · 113 citations · Full text

Medicine, Molecular Biology, Oncology +17

CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer

Alex D. Michaels, Timothy E. Newhook, Sara J. Adair et al. · Clinical Cancer Research · 2017 · 104 citations · Full text

Medicine, Immunology, Oncology +17